Immune Response after Three Doses of Hepatitis B Vaccine among Children below Five Years of Age in Mwanza, Tanzania

Delfina R. Msanga; Raphael Rwezaula; Semvua Kilonzo; Elizabeth Kwiyolecha; Tulla Masoza; Emmanuel Mkumbo; Mariam M. Mirambo

doi:10.34257/GJMRCVOL20IS5PG25

Authors

Delfina R. Msanga
Raphael Rwezaula
Semvua Kilonzo
Elizabeth Kwiyolecha
Tulla Masoza
Emmanuel Mkumbo
Mariam M. Mirambo

Keywords:

hepatitis B, children, immune response, seroconversion, mwanza, Tanzania

Abstract

Abstract not found

Downloads

How to Cite

Immune Response after Three Doses of Hepatitis B Vaccine among Children below Five Years of Age in Mwanza, Tanzania. (2021). Global Journal of Medical Research, 20(C5), 25-31. https://doi.org/10.34257/GJMRCVOL20IS5PG25

Download Citation

References

D Lavanchy Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging 16.

A Jafarzadeh, Sajadi S: Persistence Of Anti-Hbs Antibodies In Healthy Iranian Children Vaccinated With Recombinanthepatitis B Vaccine And Response To A Booster Dose (2005) Unknown Title.

Hsu-Mei Hsu, Shin-Chwen Lee, Ming-Ching Wang, Szu-Fong Lin, Ding-Shinn Chen (2001) Efficacy of a mass hepatitis B immunization program after switching to recombinant hepatitis B vaccine: a population-based study in Taiwan. 19(20-22), 2825-2829.

L Karaoglu, E Pehlivan, G Gunes, M Genc, S Tekerekoglu, C Ercan, M Egri, S Yologlu (2003) Evaluation of the immune response to hepatitis B vaccination in children aged 1-3 years in Malatya, Turkey. 26(4), 311-319.

World Health Organization (2017) Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations. 37(2), 223-225.

Arezoo Aghakhani, Mohammad Banifazl, Nabiallah Izadi, Willi Mcfarland, Masoomeh Sofian, Akbar Khadem-Sadegh, Zahra Pournasiri, Maryam Foroughi, Ali Eslamifar, Amitis Ramezani (2011) Persistence of antibody to hepatitis B surface antigen among vaccinated children in a low hepatitis B virus endemic area. 7(4), 358-360.

Hilton Whittle, Shabbar Jaffar, Michael Wansbrough, Maimuna Mendy, Uga Dumpis, Andrew Collinson, Andrew Hall (2002) Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children. 325(7364), 569.

David Yiu-Kuen But, Ching-Lung Lai, Wei-Ling Lim, James Fung, Danny Ka-Ho Wong, Man-Fung Yuen (2008) Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report. 26(51), 6587-6591.

Faleh Alfaleh, Suliman Alshehri, Saleh Alansari, Mohammed Aljeffri, Yaqoub Almazrou, Ahmad Shaffi, Ayman Abdo (2008) Long-term protection of hepatitis B vaccine 18 years after vaccination. 57(5), 404-409.

Ivana Knezevic, Vasee Moorthy, Rebecca Sheets (1999) WHO consultation on clinical evaluation of vaccines, 17-18 July 2014, WHO Headquarters, Geneva, Switzerland. 33(17), 1999-2003.

S Kuhail, R El Khodary, F Ahmed (1996) Evaluation of the routine hepatitis B immunization programme in Palestine,1996. 6(5-6), 864-869.

H Dahifar (2004) Immunogenicity of Cuban hepatitis B vaccine in Iranian children. 7(2), 89-92.

Loredana Goncalves, Benibelks Albarran, Siham Salmen, Lerida Borges, Howard Fields, Henry Montes, Andres Soyano, Yuleima Diaz, Lisbeth Berrueta (2004) The nonresponse to hepatitis B vaccination is associated with impaired lymphocyte activation. 326(1), 20-28.

G Kardar, M Jeddi‐tehrani, F Shokri (2002) Diminished Th1 and Th2 Cytokine Production in Healthy Adult Nonresponders to Recombinant Hepatitis B Vaccine. 55(3), 311-314.